Skip to main navigation Skip to search Skip to main content

Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study

Translated title of the contribution: Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study
  • L.V. Beerepoot
  • , P.O. Witteveen
  • , G. Groenewegen
  • , W.E. Fogler
  • , B.K. Sim
  • , C. Sidor
  • , B.A. Zonnenberg
  • , F.M. Schramel
  • , M.F.B.G. Gebbink
  • , E.E. Voest

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRecombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study
Original languageUndefined/Unknown
Pages (from-to)4025-4033
Number of pages9
JournalClinical Cancer Research
Volume9
Issue number11
Publication statusPublished - 2003

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Other medical specialities

Cite this